跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14,212 条关于
“CAP-IASLC-AMP”
全部
14,212
临床试验
8,887
药物
2,860
机构
88
资讯
2,377
2年前
Global Survey Reveals Persistent Barriers to Lung Cancer Biomarker Testing Despite Growing Recognition
去年
LUNAR Trial Update: Tisotumab Vedotin Shows Promise in Advanced NSCLC
8个月前
Amphastar Secures Exclusive Rights to Synthetic ACTH Analog AMP-110 in $158 Million Deal
16天前
Caris Life Sciences to Present Seven Precision Oncology Studies at IASLC 2026 World Conference on Lung Cancer
2年前
Capricor Therapeutics Gains FDA Alignment on HOPE-3 Trial Design for CAP-1002 in Duchenne Muscular Dystrophy
2个月前
Canada Invests $892,122 in AI-Driven Antimicrobial Peptide Research to Combat Antibiotic Resistance in Poultry
去年
Advancements in PD-L1 Immunohistochemistry and Digital Pathology
去年
NurExone's ExoPTEN Receives Orphan Medicinal Product Designation from EMA
去年
CAP-002 Gene Therapy Receives FDA Orphan Drug Designation for STXBP1 Disorder
2年前
HOPE-3 Trial of CAP-1002 for Duchenne Muscular Dystrophy to Proceed Following Positive Futility Analysis
第 1 页,共 238 页
上一页
下一页